Pacira BioSciences, Inc.PCRXNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
1.76
↓ 68% below average
Average (9y)
5.48
Historical baseline
Range
High:11.06
Low:1.76
CAGR
-18.5%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 1.76 | -40.4% |
| 2023 | 2.95 | -18.6% |
| 2022 | 3.62 | -38.8% |
| 2021 | 5.92 | -15.0% |
| 2020 | 6.97 | +36.2% |
| 2019 | 5.12 | -10.0% |
| 2018 | 5.69 | -20.1% |
| 2017 | 7.12 | +54.3% |
| 2016 | 4.61 | -58.3% |
| 2015 | 11.06 | - |